Get the Stockscreener App
0.351
2.53%
-0.0091
Bionexus Gene Lab Corp stock is traded at $0.351, with a volume of 41,096.
It is down -2.53% in the last 24 hours and down -7.63% over the past month.
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
See More
Previous Close:
$0.3601
Open:
$0.35
24h Volume:
41,096
Relative Volume:
0.01
Market Cap:
$6.31M
Revenue:
$9.26M
Net Income/Loss:
$-941.60K
P/E Ratio:
-4.875
EPS:
-0.072
Net Cash Flow:
$-2.65M
1W Performance:
+1.74%
1M Performance:
-7.63%
6M Performance:
-12.25%
1Y Performance:
-50.72%
1-Day Range:
$0.35
$0.37
1-Week Range:
$0.345
$0.405
52-Week Range:
$0.2105
$1.00
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1898 | 400.55M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.73 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.68 | 115.41M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
5.15 | 66.99M | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
86.24 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
Bionexus Gene Lab enters partnership with ML Tech - Yahoo Finance
BioNexus Gene Lab Taps ML Tech for AI-Driven Ethereum Growth - TOKENPOST
BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy - The Manila Times
Continued Unit Revenue Growth - The Manila Times
BioNexus Gene Lab partners with ML Tech to optimize Ethereum growth strategies - Investing.com
Can AI Transform Corporate Ethereum Management? BioNexus Thinks So - StockTitan
Full Stock Market News from 2025-03-07 - StockTitan
BioNexus Pivots Ethereum as Primary Treasury Asset - Tekedia
Ethereum price forecast: Liquidity conditions to dictate direction amid sour sentiment - TU News
@0x1Tax - Binance
Bionexus Gene Lab Corp Makes History With Ethereum-Focused Treasury Strategy - Binance
Ethereum ETF Flows Fluctuate as Market Uncertainty Continues - The Currency Analytics
BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy - idfspokesperson.com
This Nasdaq company chooses Ethereum as a strategic reserve - Passionategeekz
Ethereum addresses containing more than 10,000 ETH decline significantly - TU News
WLFI boosts $10 million in ETH and $10 million in Wrapped Bitcoin for week - TU News
BioNexus Gene Lab becomes first public company with Ethereum reserves - TU News
Bionexus Gene Lab becomes the first Nasdaq-Genter company that embraces Ethereum as Treasury Asset - Passionategeekz
BioNexus Gene Lab Becomes First Nasdaq-Listed Company to Embrace Ethereum as Treasury Asset - BeInCrypto
Ethereum ETF flows fluctuate – What’s next for ETH? - AMBCrypto News
PA Daily | Trump family project WLFI increases holdings of ETH, WBTC and MOVE; BTC whale with a cost price of nearly $10,000 is suspected of selling BTC - PANews
Medical Tech Firm BioNexus Gene Lab Announces New Ethereum-Focused Treasury Strategy - Cryptonews
BioNexus Stock Pops As It Embraces Ethereum-Focused Treasury Strategy, Says It Is First On Nasdaq To Do So - MSN
BioNexus Gene Lab Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper - Investing.com Canada
Bionexus Gene Lab Corp Announces Board Approval Of Ethereum Treasury Strategy And Release Of Strategic Whitepaper - Marketscreener.com
BioNexus Gene Lab adopts Ethereum for treasury strategy - Investing.com India
BioNexus Gene Lab adopts Ethereum for treasury strategy By Investing.com - Investing.com UK
BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic - EIN News
Nasdaq First: How BioNexus Is Betting Its Treasury on Ethereum's Future - StockTitan
Why Mettler-Toledo (MTD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Trex Company price target lowered to $71 from $81 at Jefferies - Yahoo Finance
4 Reasons Why Bitcoin (BTC) Dumped By $13,000 Since Friday - Binance
BioNexus Gene Lab issues unique preferred stock By Investing.com - Investing.com Canada
BioNexus Gene Lab issues unique preferred stock - Investing.com India
Japanese Game Firm to Allocate $6.58 Million for Bitcoin Acquisition - Binance
Why SpringWorks Therapeutics Inc. (SWTX) Soared on Monday - Yahoo Finance
Here’s Why Newell Brands Inc. (NWL) Crashed on Friday - Yahoo Finance
Rocket Lab Stock Jumps Following Director's Share Sale - Yahoo Finance
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why AT&T Inc. (T) Surged on Monday - Yahoo Finance
Hudson Technologies (HDSN) Stock Drops Amid Market Volatility - GuruFocus.com
Vitalik Buterin proposes technical upgrades to improve Ethereum scalability - TU News
SunCoke Energy, Inc. Announces Fourth Quarter 2024 Earnings Date - Yahoo Finance
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Ethereum faces criticism as Solana surges 18%, Buterin reveals EF changes - TU News
Activist investor Starboard Value takes 7.7% stake in chipmaker Qorvo - Yahoo Finance
Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Increases By 79.6% - Defense World
BOK Financial Corporation Announces Fourth Quarter 2024 Earnings Conference Call - Yahoo Finance
Arogo Capital Acquisition Successfully Extends Business Combination Deadline and Eliminates Redemption LimitationUNITED STATES SECURITIES AND EXCHANGE COMMISSION, Washington, D.C. 20549, FORM 8-K, CURRENT REPORT PURSUANT T - Defense World
IQVIA Holdings Inc. (NYSE:IQV) Receives $255.82 Consensus PT from Analysts - Defense World
BioNexus Gene Lab Receives Temporary Exception from Nasdaq Bid Price RuleOn December 27, 2024, BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced in a recent 8-K filing that it has been granted a temporary exception by the Nasdaq Hearings Pa - Defense World
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):